Caplin Point Laboratories Limited — Important, 21-08-2026: Updates
21-08-2026 | 07:12 pm
21-08-2026 | 07:12 pm
Caplin Steriles (subsidiary) received 10 procedural observations on Form 483 after a US FDA inspection at its Gummidipoondi facility. No data integrity issues or repeat observations. The company is addressing the findings for resolution.
No comments yet. Be the first to comment!
